Drugs / DC-cholesterol liposome
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00009841 Background | Mar 1999 → Mar 2002 | head and neck cancer | University of Pittsburgh | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC-cholesterol liposome | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00009841 ↗ |
| Route | Other | “Patients receive EGFR antisense DNA and DC-chol liposomes intratumorally weekly for 4 weeks.” NCT00009841 ↗ |